Dr. Andreea Elena Neamtu, MD

Dr. Neamtu practices at Saint Mary's Hospital in Waterbury, Connecticut, part of Trinity Health.

Dr. Neamtu's NPI, 1689929168, was assigned on July 19, 2012. Dr. Neamtu holds Connecticut license 54130.

Dr. Neamtu's primary practice is Saint Mary's Hospital, at 56 Franklin Street, Waterbury, CT 06706 in New Haven County. The practice phone is (203) 709-6020.

Dr. Neamtu's primary practice is Saint Mary's Hospital in Waterbury, Connecticut, part of Trinity Health. Dr. Neamtu is also affiliated with Griffin Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Neamtu to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neamtu practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Neamtu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Neamtu is licensed in Connecticut.

CMS data shows 423 Medicare services from Dr. Neamtu across 5 procedure codes in 2024, for 178 Medicare patients. Medicare paid $40,806 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Neamtu in 2024. The largest group is 85 and over, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Neamtu's median patient age at 74, with 48% women.

In 2024, Dr. Neamtu wrote 168 Medicare Part D claims for 77 patients. 84% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Neamtu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Dr. Neamtu from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $191.